FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039148081> ?p ?o ?g. }

• W2039148081 endingPage "R142" @default.
• W2039148081 startingPage "R142" @default.
• W2039148081 abstract "Rheumatoid arthritis (RA) is associated with a high cardiovascular disease (CVD) risk, whereas arterial hypertension is a major modifiable CVD risk factor with still unclear prevalence in RA disease. We conducted a comprehensive study on hypertension characteristics evaluating for the first time out-of-office blood pressure (BP) in a typical contemporary RA cohort. Assessment of office and out-of-office BP (when office systolic/diastolic BP was >129/79) and vascular studies including evaluation of aortic stiffness, carotid hypertrophy/plaques and ankle-brachial index, were performed in 214 consecutive, consenting RA patients free of CVD (aged 58.4 ± 12.3 years, 82% women). As comparators regarding office hypertension measurements, data from 214 subjects (1:1 matched for age and gender with the RA patients) derived from a cohort designed to assess the prevalence of hypertension in the general population were used. The prevalence of declared known hypertension in the RA population was 44%. Of the remaining RA patients, 2 in every 5 individuals had abnormal office BP (systolic/diastolic >139/89 mmHg), contributing to almost double the prevalence of declared/office hypertension compared to the general matched population (67% vs. 34%). Out-of-office (home or ambulatory 24 hour) BP measurements revealed that: (i) a 54% prevalence of actual hypertension in RA, in other words almost 10% of the patients were unaware of having hypertension and (ii) 29% of the RA patients with known hypertension were not well controlled. Actual hypertension was positively associated with age and body mass index, and inversely with the use of biologic drugs. Overall, almost 1 out of 5 presented the 'white coat’ phenomenon. An intermediately compromised vascular phenotype was evident in this “white coat” subgroup (lying between patients with sustained normotension and sustained hypertension) in terms of aortic stiffness, carotid hypertrophy and ankle-brachial index, even after adjustment for confounders. Beyond any doubt on the basis of out-of-office evaluation, arterial hypertension in RA has a high prevalence, low awareness and poor control, as well as substantial and vascular damage-associated “white coat” phenomenon. Thus, correct diagnosis and effective treatment of hypertension is of key importance in RA for CVD risk reduction." @default.
• W2039148081 created "2016-06-24" @default.
• W2039148081 creator A5007341235 @default.
• W2039148081 creator A5020372542 @default.
• W2039148081 creator A5021398096 @default.
• W2039148081 creator A5023477676 @default.
• W2039148081 creator A5024867657 @default.
• W2039148081 creator A5033228211 @default.
• W2039148081 creator A5046071415 @default.
• W2039148081 creator A5047358407 @default.
• W2039148081 creator A5091526979 @default.
• W2039148081 date "2013-01-01" @default.
• W2039148081 modified "2023-10-06" @default.
• W2039148081 title "Arterial hypertension assessed “out-of-office” in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated “white coat” phenomenon" @default.
• W2039148081 cites W1536186020 @default.
• W2039148081 cites W1934027766 @default.
• W2039148081 cites W1967610947 @default.
• W2039148081 cites W1978710215 @default.
• W2039148081 cites W1979346554 @default.
• W2039148081 cites W1984241213 @default.
• W2039148081 cites W1989739674 @default.
• W2039148081 cites W1993727635 @default.
• W2039148081 cites W1994144670 @default.
• W2039148081 cites W1995700710 @default.
• W2039148081 cites W2015410646 @default.
• W2039148081 cites W2017281076 @default.
• W2039148081 cites W2024990134 @default.
• W2039148081 cites W2026962303 @default.
• W2039148081 cites W2029157695 @default.
• W2039148081 cites W2041051273 @default.
• W2039148081 cites W2042134474 @default.
• W2039148081 cites W2051952778 @default.
• W2039148081 cites W2063997025 @default.
• W2039148081 cites W2064192867 @default.
• W2039148081 cites W2069959649 @default.
• W2039148081 cites W2071440314 @default.
• W2039148081 cites W2075702931 @default.
• W2039148081 cites W2091045532 @default.
• W2039148081 cites W2103777208 @default.
• W2039148081 cites W2107023223 @default.
• W2039148081 cites W2108783776 @default.
• W2039148081 cites W2116705316 @default.
• W2039148081 cites W2119227351 @default.
• W2039148081 cites W2130583714 @default.
• W2039148081 cites W2141487147 @default.
• W2039148081 cites W2147811682 @default.
• W2039148081 cites W2148560707 @default.
• W2039148081 cites W2149308565 @default.
• W2039148081 cites W2152077553 @default.
• W2039148081 cites W2152348310 @default.
• W2039148081 cites W2155121555 @default.
• W2039148081 cites W2155159583 @default.
• W2039148081 cites W2158716968 @default.
• W2039148081 cites W2169741728 @default.
• W2039148081 cites W2170108033 @default.
• W2039148081 cites W41201517 @default.
• W2039148081 cites W4232411700 @default.
• W2039148081 doi "https://doi.org/10.1186/ar4324" @default.
• W2039148081 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3978881" @default.
• W2039148081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24286134" @default.
• W2039148081 hasPublicationYear "2013" @default.
• W2039148081 type Work @default.
• W2039148081 sameAs 2039148081 @default.
• W2039148081 citedByCount "38" @default.
• W2039148081 countsByYear W20391480812014 @default.
• W2039148081 countsByYear W20391480812015 @default.
• W2039148081 countsByYear W20391480812016 @default.
• W2039148081 countsByYear W20391480812017 @default.
• W2039148081 countsByYear W20391480812018 @default.
• W2039148081 countsByYear W20391480812019 @default.
• W2039148081 countsByYear W20391480812020 @default.
• W2039148081 countsByYear W20391480812021 @default.
• W2039148081 countsByYear W20391480812022 @default.
• W2039148081 countsByYear W20391480812023 @default.
• W2039148081 crossrefType "journal-article" @default.
• W2039148081 hasAuthorship W2039148081A5007341235 @default.
• W2039148081 hasAuthorship W2039148081A5020372542 @default.
• W2039148081 hasAuthorship W2039148081A5021398096 @default.
• W2039148081 hasAuthorship W2039148081A5023477676 @default.
• W2039148081 hasAuthorship W2039148081A5024867657 @default.
• W2039148081 hasAuthorship W2039148081A5033228211 @default.
• W2039148081 hasAuthorship W2039148081A5046071415 @default.
• W2039148081 hasAuthorship W2039148081A5047358407 @default.
• W2039148081 hasAuthorship W2039148081A5091526979 @default.
• W2039148081 hasBestOaLocation W20391480811 @default.
• W2039148081 hasConcept C126322002 @default.
• W2039148081 hasConcept C149323552 @default.
• W2039148081 hasConcept C164705383 @default.
• W2039148081 hasConcept C1862650 @default.
• W2039148081 hasConcept C198451711 @default.
• W2039148081 hasConcept C2775850156 @default.
• W2039148081 hasConcept C2777575956 @default.
• W2039148081 hasConcept C2780221984 @default.
• W2039148081 hasConcept C2908647359 @default.
• W2039148081 hasConcept C71924100 @default.
• W2039148081 hasConcept C72563966 @default.
• W2039148081 hasConcept C84393581 @default.
• W2039148081 hasConcept C99454951 @default.

• next